首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention
【2h】

Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention

机译:经皮冠状动脉介入治疗后急性ST段抬高型心肌梗死和非ST段抬高型急性冠状动脉综合征患者的长期死亡率比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and aims: This study is to compare the short-term and long-term mortality in patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation acute coronary syndrome (NSTE-ACS) after percutaneous coronary intervention (PCI). Methods and results: A total of 266 STEMI patients and 140 NSTE-ACS patients received PCI. Patients were followed up by telephone or at medical record or case statistics center and were followed up for 4 years. Descriptive statistics and multivariate survival analyses were employed to compare the mortality in STEMI and NSTE-ACS. All statistical analyses were performed by SPSS19.0 software package. NSTE-ACS patients had significantly higher clinical and angiographic risk profiles at baseline. During the 4-year follow-up, all-cause mortality in STEMI was significantly higher than that in NSTE-ACS after coronary stent placement (HR 1.496, 95% CI 1.019-2.197). In a landmark analysis no difference was seen in all-cause mortality for both STEMI and NSTE-ACS between 6 month and 4 years of follow-up (HR 1.173, 95% CI 0.758-1.813). Conclusions: Patients with STEMI have a worse long-term prognosis compared to patients with NSTE-ACS after PCI, due to higher short-term mortality. However, NSTE-ACS patients have a worse long-term survival after 6 months.
机译:背景与目的:本研究旨在比较经皮冠状动脉介入治疗后ST段抬高型心肌梗死(STEMI)和非ST段抬高型急性冠脉综合征(NSTE-ACS)患者的短期和长期死亡率( PCI)。方法和结果:266例STEMI患者和140例NSTE-ACS患者接受了PCI。通过电话或病历或病例统计中心对患者进行随访,并随访4年。采用描述性统计和多元生存分析比较STEMI和NSTE-ACS的死亡率。所有统计分析均通过SPSS19.0软件包执行。 NSTE-ACS患者在基线时具有显着较高的临床和血管造影风险。在4年的随访期间,置入冠状动脉支架后STEMI的全因死亡率显着高于NSTE-ACS(HR 1.496,95%CI 1.019-2.197)。在一项具有里程碑意义的分析中,在随访的6个月至4年之间,STEMI和NSTE-ACS的全因死亡率均无差异(HR 1.173,95%CI 0.758-1.813)。结论:与PCI后NSTE-ACS患者相比,STEMI患者的长期预后较差,原因是短期死亡率较高。但是,NSTE-ACS患者在6个月后的长期生存期较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号